MedPace) is a midsize, clinical contract research organization (CRO) based in Cincinnati, Ohio. It provides services for Phase I-IV of drug and medical device development services including regulatory services and central laboratory services. The company started trading stock as a public firm in 2016.

Is medpace a good place to work?

Medpace has a lot of very good people working for the company. Leadership does not fully appreciate the employees. Very stressful and low pay across the company. Health insurance is very expensive and there is no tuition reimbursement of any kind.

Is medpace a CRO?

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.

What is medpace known for?

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries.

Why do you want to work at medpace?

Our employees provide hope for those living with debilitating diseases. We invite you to be a part of something that is impacting millions of people around the globe while enjoying a competitive total compensation and benefits package and internal growth opportunities.

What does CRO mean?

CRO

AcronymDefinition
CROChief Risk Officer (corporate title)
CROContract Research Organization (aka Clinical Research Organization)
CROCroatia
CROClinical Research Organization (Pharmaceutical/Regulatory)

What is a full service CRO?

A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. CROs range from large, international full-service organizations to small, niche specialty groups.

Why medmedpace for your clinical trials?

Medpace puts over 25 years of global experience to work for you. Experienced medical leadership with a thorough understanding of the complex conditions that cause autoimmune diseases. Effectively plan, conduct, and integrate your cardiovascular and cardiac safety trials regardless of trial size or safety demands.

Why medmedpace for E14 studies?

Medpace is a member of the Cardiac Safety Research Consortium, and very well versed in the recent updates to the E14 guidelines allowing rigorous ECG assessments in Phase I ascending dose SAD/MAD studies to potentially replace TQT studies. Located on the same campus as MCL, providing an optimal environment for cardiac safety studies

What is medmedpace doing for TQT research?

Medpace is an executive committee member of the Cardiac Safety Research Consortium, and has extensive experience in the design of TQT studies

How does Medpace help with regulatory submissions?

The Medpace team will compile the statistical results and resulting medical conclusions and medical writing services needed for regulatory submission, and if required, work with your team to present the data to regulatory bodies